The importance of reviewing and studying sex-based differences in pharmacologic parameters
is demonstrated by the increasing data on gender variation in drug efficacy and toxicity …

… Greenblatt, … Gandhi M, Aweeka F, Greenblatt RM, Blaschke TF. Sex differences in
pharmacokinetics and pharmacodynamics. Annu Rev Pharmacol Toxicol. … Gandhi M …

Little is known about the epidemiology of anal human papillomavirus (HPV) infection in
women. We studied 251 human immunodeficiency virus (HIV)—positive and 68 HIV-negative …

Among 115 heterosexual men who presented with genital ulcers to a sexually transmitted
disease clinic in Nairobi, Kenya, the prevalence of serum antibody to HIV was 16.5%. A past …

Background: Anal cancers are thought to arise from squamous intraepithelial lesions in the
anal canal, and women infected with human immunodeficiency virus-1 (HIV) may be at …

The National Institutes of Health established the Women’s Interagency HIV Study (WIHS) in
1993 to study the impact and progression of HIV infection among women in response to the …

<p>The development of AIDS interventions for adolescents is hindered by the lack of data
on the conditions that influence high‐risk sexual behavior. We examined psychosocial …

Objective: To assess the association between protease inhibitor (PI) use and the incidence
of diabetes mellitus (DM) among participants in the Women's Interagency HIV Study. Design: …

OBJECTIVE: To compare serum müllerian inhibiting substance (MIS) levels between white,
black, and Hispanic women to determine whether ovarian aging occurs at a different time …

We undertook a critical epidemiological review of the available evidence concerning whether
women have lower levels of human immunodeficiency virus (HIV) RNA than do men at …